Bank of America’s Monte Rosa Therapeutics GLUE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.22M | Buy |
271,164
+245,119
| +941% | +$1.11M | ﹤0.01% | 4329 |
|
|
2025
Q1 | $121K | Sell |
26,045
-37,238
| -59% | -$173K | ﹤0.01% | 5431 |
|
|
2024
Q4 | $439K | Sell |
63,283
-10,136
| -14% | -$70.3K | ﹤0.01% | 4812 |
|
|
2024
Q3 | $389K | Buy |
73,419
+4,916
| +7% | +$26.1K | ﹤0.01% | 4810 |
|
|
2024
Q2 | $256K | Buy |
68,503
+6,394
| +10% | +$23.9K | ﹤0.01% | 4954 |
|
|
2024
Q1 | $438K | Sell |
62,109
-18,598
| -23% | -$131K | ﹤0.01% | 4627 |
|
|
2023
Q4 | $456K | Sell |
80,707
-893
| -1% | -$5.05K | ﹤0.01% | 4682 |
|
|
2023
Q3 | $391K | Sell |
81,600
-2,462
| -3% | -$11.8K | ﹤0.01% | 4643 |
|
|
2023
Q2 | $576K | Buy |
84,062
+34,140
| +68% | +$234K | ﹤0.01% | 4391 |
|
|
2023
Q1 | $389K | Sell |
49,922
-29,227
| -37% | -$228K | ﹤0.01% | 4781 |
|
|
2022
Q4 | $602K | Sell |
79,149
-27,178
| -26% | -$207K | ﹤0.01% | 4557 |
|
|
2022
Q3 | $869K | Sell |
106,327
-19,913
| -16% | -$163K | ﹤0.01% | 4287 |
|
|
2022
Q2 | $1.22M | Sell |
126,240
-21,434
| -15% | -$207K | ﹤0.01% | 4093 |
|
|
2022
Q1 | $2.07M | Buy |
147,674
+82,018
| +125% | +$1.15M | ﹤0.01% | 3961 |
|
|
2021
Q4 | $1.34M | Sell |
65,656
-13,845
| -17% | -$283K | ﹤0.01% | 4271 |
|
|
2021
Q3 | $1.77M | Buy |
+79,501
| New | +$1.77M | ﹤0.01% | 3897 |
|